Pfizer posts 4Q loss, misses Street views, on lower revenue
Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a slight miss of Wall Street's profit expectations. The…
Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a slight miss of Wall Street's profit expectations. The…
